SynAct Pharma AB · FWB:8F8

SynAct Pharma AB financial statements

SynAct Pharma AB's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in SEK

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue00000000
Cost of revenue617.0K778.0K1.06M88.0K338.5K303.6K252.0K190.4K
Gross profit00000-338.5K-303.6K-252.0K-190.4K
Research and development85.6M49.3M105.1M70.1M60.5M22.8M15.2K21.8M
Selling, general and administrative31.5M40.5M33.9M35.6M16.2M8.81M24.2M28.1M17.9M
Operating income-116.5M-90.0M-224.5M-105.7M-76.7M-31.3M-24.8M-28.4M-18.2M-17.0M
Depreciation and amortization628.0K614.0K75.3M1.02M88.0K381.1K338.5K303.6K252.0K190.4K
EBITDA-115.9M-89.4M-149.2M-104.7M-76.6M-30.9M-24.5M-28.1M-17.9M-16.8M
Interest expense3.87M2.96M830.0K1.42M110.0K39.0K2.39M146.7K155.4K
Income before tax-119.0M-90.8M-224.3M-107.1M-76.8M-31.3M-27.1M-28.2M-18.0M-17.0M
Income tax-8.16M-8.42M-8.47M-7.86M-7.50M-4.75M-3.15M-4.80M-2.64M-1.54M
Net income-110.8M-82.4M-215.8M-99.2M-69.3M-26.6M-24.0M-23.4M-15.4M-15.5M
Earnings per share, basic-2.17-2.08-6.64-3.60-2.68-1.23-1.62-1.70-1.24-1.30
Earnings per share, diluted-2.17-2.08-6.64-3.60-2.68

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents53.4M61.2M62.4M108.2M24.0M14.5M3.56M7.12M10.2M26.6M
Short-term investments93.0K180.0K-208.0K
Receivables13.4M5.96M12.4M14.7M10.7M6.46M4.90M6.02M3.87M2.92M
Inventory-12.4M246.0K321.0K-22.2K-6.02M-3.87M-2.92M
Current assets71.3M94.0M75.1M140.2M34.9M21.3M8.45M13.1M14.1M29.5M
Property, plant and equipment2.10M3.18M
Goodwill0000
Total assets220.5M270.5M228.0M142.6M38.4M21.6M23.8M14.0M15.2M30.6M
Accounts payable9.49M17.3M9.67M4.72M4.25M2.77M5.46M3.23M1.78M3.16M
Current liabilities21.5M28.5M24.9M15.0M15.4M5.72M10.3M3.72M2.31M3.49M
Total debt1.81M1.88M637.0K2.06M3.09M
Total liabilities50.2M56.4M51.8M16.1M17.5M5.72M10.3M3.72M2.31M3.49M
Shareholders' equity170.3M214.2M176.2M126.5M20.9M15.9M13.5M10.3M12.9M27.1M
Shares outstanding51.1M39.5M32.5M27.6M26.0M21.7M14.8M13.8M12.4M11.9M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-97.3M-89.2M-100.2M-117.6M-65.0M-33.2M-16.1M-24.2M-17.2M-14.7M
Capital spending00000-33.2M-499.0K0-264.5K-903.0K
Free cash flow-97.3M-89.2M-100.2M-117.6M-65.0M-33.2M-16.6M-24.2M-17.5M-15.6M
Cash from investing00370.0K27.0K-6.00K-93.0K-499.0K-93.0K-264.5K-996.1K
Cash from financing90.5M87.4M54.0M200.7M74.3M44.7M13.0M20.8M950.9K42.1M
Change in cash-6.87M-1.79M-45.8M83.2M9.32M11.0M-3.56M-3.09M-16.4M25.8M